Your browser doesn't support javascript.
loading
In vitro activity of ceftobiprole and dalbavancin against a collection of coagulase-negative staphylococci isolates from clinical samples with reduced susceptibility to daptomycin and/or resistant to linezolid or glycopeptides.
Velasco de la Fuente, Silvia; Fernández-Martinez, Marta; Rodríguez Lozano, Jesús; Pablo-Marcos, Daniel; Siller, María; Calvo, Jorge.
Affiliation
  • Velasco de la Fuente S; Microbiology Service, University Hospital Marqués de Valdecilla - IDIVAL, Santander, Spain. Electronic address: silviavefu@gmail.com.
  • Fernández-Martinez M; Microbiology Service, University Hospital Marqués de Valdecilla - IDIVAL, Santander, Spain.
  • Rodríguez Lozano J; Microbiology Service, University Hospital Marqués de Valdecilla - IDIVAL, Santander, Spain.
  • Pablo-Marcos D; Microbiology Service, University Hospital Marqués de Valdecilla - IDIVAL, Santander, Spain.
  • Siller M; Microbiology Service, University Hospital Marqués de Valdecilla - IDIVAL, Santander, Spain.
  • Calvo J; Microbiology Service, University Hospital Marqués de Valdecilla - IDIVAL, Santander, Spain.
Enferm Infecc Microbiol Clin (Engl Ed) ; 41(9): 567-570, 2023 11.
Article in En | MEDLINE | ID: mdl-36707282
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Staphylococcal Infections / Daptomycin Limits: Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Staphylococcal Infections / Daptomycin Limits: Humans Language: En Year: 2023 Type: Article